Abstract
The purpose of this study was to characterize recent alcohol brief intervention (ABI) efficacy and effectiveness trials, summarize outcomes, and show how variability in outcomes and reporting compromises the evidence base. A systematic review and narrative synthesis of articles from 10 databases were undertaken (January 2000-November 2017); study selection represented recent, readily available publications. The National Institute of Care Excellence (NICE) Public Health Guideline 24 (Alcohol use disorders: prevention) informed ABI definitions. The review was conducted using Centre for Reviews and Dissemination (CRD) guidance and pre-registered on PROSPERO (CRD42016047185). Seven a priori specified domains were used to classify outcomes: biomarkers, alcohol-related outcomes, economic factors/resource use, health measures, life impact, intervention factors, and psychological/behavioral factors. The search identified 405 trials from 401 eligible papers. In 405 trials, 2,641 separate outcomes were measured in approximately 1,560 different ways. The most common outcomes used were the number of drinks consumed in a week and frequency of heavy episodic drinking. Biomarkers were least frequently used. The most common primary outcome was weekly drinks. By trial type, the most frequent outcome in efficacy and effectiveness trials was frequency of heavy drinking. Consumption outcomes predominated; however, no single outcome was found in all trials. This comprehensive outcome map and methodological detail on ABI effectiveness and efficacy trials can aid decision making in future trials. There was a diversity of instruments, time points, and outcome descriptions in methods and results sections. Compliance with reporting guidance would support data synthesis and improve trial quality. This review establishes the need for a core outcome set (COS)/minimum data standard and supports the Outcome Reporting in Brief Interventions: Alcohol initiative (ORBITAL) to improve standards in the ABI field through a COS for effectiveness and efficacy randomized trials.
Highlights
ALCOHOL BRIEF INTERVENTIONS (ABIs) are key strategies to address problematic alcohol use worldwide (Coffield et al, 2001; National Institute for Health and Care Excellence [National Institute of Care Excellence (NICE)], 2010; U.S Preventive Services Task Force, 2004; World Health Organization [WHO], 2016)
Higher numbers were randomized in primary care, emergency department, and general population samples compared with the remaining populations (Table 1)
This review is the first to go beyond stating outcome heterogeneity as a weakness in ABI systematic reviews; it quantifies the heterogeneity and inconsistency in outcomes reported in effectiveness and efficacy trials of ABIs
Summary
ALCOHOL BRIEF INTERVENTIONS (ABIs) are key strategies to address problematic alcohol use worldwide (Coffield et al, 2001; National Institute for Health and Care Excellence [NICE], 2010; U.S Preventive Services Task Force, 2004; World Health Organization [WHO], 2016). Many systematic reviews (Ballesteros et al, 2003, 2004a, 2004b; Beich et al, 2003; Bertholet et al, 2005; Kaner et al.,
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
